1. Home
  2. ANNX vs AVO Comparison

ANNX vs AVO Comparison

Compare ANNX & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.36

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$11.17

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
AVO
Founded
2011
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
812.7M
1.0B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ANNX
AVO
Price
$5.36
$11.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$16.50
$17.00
AVG Volume (30 Days)
2.1M
864.8K
Earning Date
05-11-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.92
EPS
N/A
N/A
Revenue
N/A
$1,391,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16,320.74
$3.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.68
52 Week Low
$1.85
$10.37
52 Week High
$7.18
$15.53

Technical Indicators

Market Signals
Indicator
ANNX
AVO
Relative Strength Index (RSI) 48.41 25.15
Support Level $4.80 $10.37
Resistance Level $5.61 $12.21
Average True Range (ATR) 0.28 0.45
MACD 0.02 -0.12
Stochastic Oscillator 55.96 0.78

Price Performance

Historical Comparison
ANNX
AVO

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

Share on Social Networks: